Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28943950)

Published in Oncol Lett on August 02, 2017

Authors

Pantipa Subhasitanont1, Daranee Chokchaichamnankit1, Khajeelak Chiablaem1, Siriporn Keeratichamroen1, Lukana Ngiwsara1, N Monique Paricharttanakul1, Kriengsak Lirdprapamongkol1, Churat Weeraphan1, Jisnuson Svasti1,2, Chantragan Srisomsap1

Author Affiliations

1: Laboratory of Biochemistry, Chulabhorn Research Institute, Bangkok 10210, Thailand.
2: Applied Biological Sciences Program, Chulabhorn Graduate Institute, Bangkok 10210, Thailand.

Articles cited by this

The heat-shock proteins. Annu Rev Genet (1988) 22.28

Caspases: enemies within. Science (1998) 19.45

Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92

RNA and disease. Cell (2009) 7.98

Polyphenols: food sources and bioavailability. Am J Clin Nutr (2004) 7.46

Identification and characterization of the packaging proteins of core 40S hnRNP particles. Cell (1977) 5.50

Protease activation during apoptosis: death by a thousand cuts? Cell (1995) 5.15

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol (1999) 3.28

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology (2005) 3.24

Escaping cell death: survival proteins in cancer. Exp Cell Res (1999) 2.73

Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol (1997) 2.64

Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem (2000) 2.47

Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology (1998) 2.19

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) (2008) 2.04

Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer (2000) 1.98

Heat-shock proteins as regulators of apoptosis. Oncogene (2003) 1.97

Caspase-activation pathways in apoptosis and immunity. Immunol Rev (2003) 1.87

Apigenin: a promising molecule for cancer prevention. Pharm Res (2010) 1.78

Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics (2007) 1.57

Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci (2004) 1.48

Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res (2004) 1.42

Heat shock proteins: stress proteins with Janus-like properties in cancer. Int J Hyperthermia (2008) 1.40

Nutraceutical--definition and introduction. AAPS PharmSci (2003) 1.38

Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells. Biochem Pharmacol (2006) 1.28

Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun (2001) 1.27

Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3. J Biol Chem (1998) 1.25

Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis (2010) 1.13

Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics (2010) 1.06

Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene (1998) 1.03

Proteomic analysis of cholangiocarcinoma cell line. Proteomics (2004) 1.03

STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia (2007) 1.02

Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc Natl Acad Sci U S A (2013) 1.01

High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res (2010) 0.97

Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells. J Clin Biochem Nutr (2009) 0.96

Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis. Leukemia (2004) 0.95

Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One (2011) 0.95

Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones (2010) 0.94

Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis (1986) 0.90

Hepatic carcinoma with opisthorchiasis. Southeast Asian J Trop Med Public Health (1978) 0.88

Protein changes associated with ionizing radiation-induced apoptosis in human prostate epithelial tumor cells. Electrophoresis (1999) 0.88

Cytosolic nuclease activated by caspase-3 and inhibited by DFF-45. Biochem Biophys Res Commun (1998) 0.87

S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J Cell Biochem (2008) 0.86

Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma. Cancer Sci (2010) 0.85

Simplified evaluation of apoptosis using the Muse cell analyzer. Postepy Biochem (2012) 0.84

Murraya koenigii leaf extract inhibits proteasome activity and induces cell death in breast cancer cells. BMC Complement Altern Med (2013) 0.83

Proteomic profiling of cholangiocarcinoma cell line treated with pomiferin from Derris malaccensis. Proteomics (2005) 0.81

Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death. J Mol Med (Berl) (2004) 0.80

Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development. J Hepatobiliary Pancreat Sci (2014) 0.79

Comparison of membrane-associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines. Proteomics Clin Appl (2006) 0.78

Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma. Int J Cancer (2015) 0.76